Rosuvastatin Tablet, Film Coated
Product Images NDC 71335-2539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71335-2539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A line graph showing cumulative incidence percentage over time in years for Rosuvastatin (Rosuva) versus placebo. The graph includes data points for number at risk at various years for RSV and placebo groups. The hazard ratio and confidence interval, along with a p-value, are noted on the graph.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table comparing the number of events for various cardiovascular end points between Rosuvastatin 20 mg and Placebo 20 mg groups. It includes hazard ratios (HR) with 95% confidence intervals and P values for endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A hazard ratio plot with confidence intervals is also shown.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
Box plot chart showing percent change from baseline in LDL-C for four statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin at varying doses (10, 20, 40 mg for Rosuvastatin and Pravastatin; 10, 20, 40, 80 mg for Atorvastatin and Simvastatin). The y-axis represents percent change in LDL-C, ranging approximately from 0 to -75%, illustrating the lipid-lowering effects of each drug dose.*
FDA Label Image

Label (Lbl713352539)

Label (Lbl713352539)
Label for Rosuvastatin Tablets USP, 10 mg film-coated tablets, packaged in a quantity of 30 tablets. The label includes the NDC 71335-2539-1 and shows that the product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. Additional text mentions storage instructions and a QR code for package insert information.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure of rosuvastatin calcium, showing detailed molecular arrangement including fluorophenyl, pyrimidine, sulfonamide, and carboxylate groups, with calcium ions represented as Ca2+.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.